These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33943048)
1. Polygenic risk score for genetic evaluation of prostate cancer risk in Asian populations: A narrative review. Song SH; Byun SS Investig Clin Urol; 2021 May; 62(3):256-266. PubMed ID: 33943048 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk-associated genetic markers and their potential clinical utility. Xu J; Sun J; Zheng SL Asian J Androl; 2013 May; 15(3):314-22. PubMed ID: 23564047 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men. Na R; Liu F; Zhang P; Ye D; Xu C; Shao Q; Qi J; Wang X; Chen Z; Wang M; He D; Wang Z; Zhou F; Yuan J; Gao X; Wei Q; Yang J; Jiao Y; Ou-Yang J; Zhu Y; Wu Q; Chen H; Lu D; Shi R; Lin X; Jiang H; Wang Z; Jiang D; Sun J; Zheng SL; Ding Q; Mo Z; Sun Y; Xu J Prostate; 2013 Nov; 73(15):1623-35. PubMed ID: 24038036 [TBL] [Abstract][Full Text] [Related]
4. Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs. Zheng J; Liu F; Lin X; Wang X; Ding Q; Jiang H; Chen H; Lu D; Jin G; Hsing AW; Shao Q; Qi J; Ye Y; Wang Z; Gao X; Wang G; Chu LW; Ouyang J; Huang Y; Chen Y; Gao Y; Shi R; Wu Q; Wang M; Zhang Z; Hu Y; Sun J; Zheng SL; Gao X; Xu C; Mo Z; Sun Y; Xu J Prostate; 2012 Apr; 72(5):577-83. PubMed ID: 21796652 [TBL] [Abstract][Full Text] [Related]
5. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies. Kim S; Shin C; Jee SH Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496 [TBL] [Abstract][Full Text] [Related]
6. Association of six susceptibility Loci with prostate cancer in northern chinese men. Zhang YR; Xu Y; Yang K; Liu M; Wei D; Zhang YG; Shi XH; Wang JY; Yang F; Wang X; Liang SY; Zhao CX; Wang F; Chen X; Sun L; Zhu XQ; Zhu L; Yang YG; Tang L; Jiao HY; Huo ZH; Yang Z Asian Pac J Cancer Prev; 2012; 13(12):6273-6. PubMed ID: 23464444 [TBL] [Abstract][Full Text] [Related]
7. Prediction of clinically significant prostate cancer using polygenic risk models in Asians. Song SH; Kim E; Woo E; Kwon E; Yoon S; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS Investig Clin Urol; 2022 Jan; 63(1):42-52. PubMed ID: 34983122 [TBL] [Abstract][Full Text] [Related]
8. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133 [TBL] [Abstract][Full Text] [Related]
9. Application of European-specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations. Ruan X; Huang D; Huang J; Xu D; Na R Prostate; 2023 Jan; 83(1):30-38. PubMed ID: 35996327 [TBL] [Abstract][Full Text] [Related]
10. Risk Allele Frequency Analysis and Risk Prediction of Single-Nucleotide Polymorphisms for Prostate Cancer. Yoon BW; Shin HT; Seo JH Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360276 [TBL] [Abstract][Full Text] [Related]
11. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes. Ren S; Xu J; Zhou T; Jiang H; Chen H; Liu F; Na R; Zhang L; Wu Y; Sun J; Yang B; Gao X; Zheng SL; Xu C; Ding Q; Sun Y Prostate; 2013 Dec; 73(16):1824-35. PubMed ID: 24037738 [TBL] [Abstract][Full Text] [Related]
12. Polygenic risk score in prostate cancer. Oh JJ; Hong SK Curr Opin Urol; 2022 Sep; 32(5):466-471. PubMed ID: 35855560 [TBL] [Abstract][Full Text] [Related]
13. Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs. Jiang H; Liu F; Wang Z; Na R; Zhang L; Wu Y; Zheng J; Lin X; Jiang D; Sun J; Zheng SL; Ding Q; Xu J Prostate; 2013 Nov; 73(15):1651-9. PubMed ID: 23868750 [TBL] [Abstract][Full Text] [Related]
14. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes. Ruan X; Huang D; Huang J; Tsu JH; Na R J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201 [TBL] [Abstract][Full Text] [Related]
15. Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening. Byrne L; Toland AE Urol Clin North Am; 2021 Aug; 48(3):387-399. PubMed ID: 34210493 [TBL] [Abstract][Full Text] [Related]
16. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study. Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662 [TBL] [Abstract][Full Text] [Related]
17. Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses. Lu Y; Sun J; Kader AK; Kim ST; Kim JW; Liu W; Sun J; Lu D; Feng J; Zhu Y; Jin T; Zhang Z; Dimitrov L; Lowey J; Campbell K; Suh E; Duggan D; Carpten J; Trent JM; Gronberg H; Zheng SL; Isaacs WB; Xu J Prostate; 2012 Mar; 72(4):376-85. PubMed ID: 21671247 [TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort. Wu Y; Ruan X; Gao P; Da H; Fang Z; Xu D; Jiang H; Ding Q; Lin X; Lu D; Na R Clin Genet; 2023 Jun; 103(6):636-643. PubMed ID: 36840471 [TBL] [Abstract][Full Text] [Related]
19. 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. Takata R; Takahashi A; Fujita M; Momozawa Y; Saunders EJ; Yamada H; Maejima K; Nakano K; Nishida Y; Hishida A; Matsuo K; Wakai K; Yamaji T; Sawada N; Iwasaki M; Tsugane S; Sasaki M; Shimizu A; Tanno K; Minegishi N; Suzuki K; Matsuda K; Kubo M; Inazawa J; Egawa S; Haiman CA; Ogawa O; Obara W; Kamatani Y; Akamatsu S; Nakagawa H Nat Commun; 2019 Sep; 10(1):4422. PubMed ID: 31562322 [TBL] [Abstract][Full Text] [Related]
20. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Liu F; Hsing AW; Wang X; Shao Q; Qi J; Ye Y; Wang Z; Chen H; Gao X; Wang G; Chu LW; Ding Q; OuYang J; Gao X; Huang Y; Chen Y; Gao YT; Zhang ZF; Rao J; Shi R; Wu Q; Wang M; Zhang Z; Zhang Y; Jiang H; Zheng J; Hu Y; Guo L; Lin X; Tao S; Jin G; Sun J; Lu D; Zheng SL; Sun Y; Mo Z; Xu J Cancer Sci; 2011 Oct; 102(10):1916-20. PubMed ID: 21756274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]